A carregar...
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
In the past decade, the development of immune checkpoint inhibitors in oncological clinical settings was in the forefront. However, the interest in musculoskeletal tumor patients as candidates for checkpoint inhibition remains underserved. Here, we are forwarding evidence proposing that galectin-3 (...
Na minha lista:
| Publicado no: | Cancer Metastasis Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7897198/ https://ncbi.nlm.nih.gov/pubmed/32929561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-020-09932-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|